EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Long-Term Treatment Outcomes and Remission Durability in Absence Epilepsy: A Nationwide Claims-Based Cohort Study

Jooyoung Lee iD, Arum Choi iD, Il Han Yoo iD

Journal of Clinical Neurology · 2026 · 22 (6) · 681

DOI: 10.3988/jcn.2026.0325 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Neurology, 2026. Verfasst von Jooyoung Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eunpyeong St. Mary's Hospital, Research Institute of Medical Science, Catholic Medical Center Research Foundation, Eunpyeong St. Mary’s Hospital, Research Institute of Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Population-level evidence comparing long-term treatment trajectories in childhood absence epilepsy (CAE) and juvenile absence epilepsy (JAE) remains limited. We evaluated claims-defined remission patterns and treatment persistence in a nationwide cohort. METHODS: Using the South Korean Health Insurance Review and Assessment Service database (2011-2025), we identified newly treated probable absence epilepsy and operationally categorized patients as CAE (index age, 0-9 years) or JAE (index age, 10-17 years). Outcomes were claims-defined first remission, antiseizure medication (ASM) reinitiation after claims-defined first remission, claims-defined final remission, and severe post-index outcomes. A multicenter chart review assessed case identification and age-based CAE/JAE concordance. RESULTS: The cohort included 1,775 patients (1,279 CAE; 496 JAE). Case identification had 78.0% sensitivity, 99.6% specificity, and 94.1% positive predictive value; age-based classification matched clinician-adjudicated CAE/JAE diagnoses in all 32 confirmed cases. In the 2013-2016 cohort with mature follow-up, claims-defined final remission occurred in 67.0% and 34.1% of CAE and JAE cases, respectively, and the median time to claims-defined final remission was 5.89 years in CAE but was not reached in JAE. JAE showed lower claims-defined first remission, more frequent ASM reinitiation after claims-defined first remission, and lower claims-defined final remission than CAE. No significant between-group difference was detected in claims-defined status epilepticus or drug-resistant epilepsy. CONCLUSIONS: This study provides population-level benchmarks for long-term outcomes in absence epilepsy. Notably, durable claims-defined ASM-free remission was not universal or rapid in CAE, and JAE showed lower remission durability and greater treatment persistence.

Schlagwörter

Stichwörter der Autor:innen

anticonvulsantschildhood absence epilepsyjuvenile absence epilepsyreal-world dataremission durabilitytreatment persistence

Autor:innen und Institutionen

  • Department of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. dr.yooilhan@gmail.com.

ORCID-Profile: Jooyoung Lee, Arum Choi, Il Han Yoo

Förderung

  • Eunpyeong St. Mary's Hospital, Research Institute of Medical Science
  • Catholic Medical Center Research Foundation
  • Eunpyeong St. Mary’s Hospital, Research Institute of Medical Science

Zitieren

APA

Lee, J., Choi, A., & Yoo, I. H. (2026). Long-Term Treatment Outcomes and Remission Durability in Absence Epilepsy: A Nationwide Claims-Based Cohort Study. Journal of Clinical Neurology, 22(6), 681. https://doi.org/10.3988/jcn.2026.0325

Vancouver

Lee J, Choi A, Yoo IH. Long-Term Treatment Outcomes and Remission Durability in Absence Epilepsy: A Nationwide Claims-Based Cohort Study. Journal of Clinical Neurology. 2026;22(6):681. doi:10.3988/jcn.2026.0325

BibTeX
@article{Lee2026,
  author = {Lee, Jooyoung and Choi, Arum and Yoo, Il Han},
  title = {Long-Term Treatment Outcomes and Remission Durability in Absence Epilepsy: A Nationwide Claims-Based Cohort Study},
  journal = {Journal of Clinical Neurology},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {681},
  doi = {10.3988/jcn.2026.0325}
}
Kostenlos starten →